Stock prices often react negatively to financial results that do not meet expectations, as well as to forecasts that indicate slower future growth. Ginkgo Bioworks Holdings' announcement of both weaker-than-expected Q4 results and a lower revenue guidance for FY24 directly impacts investor sentiment and the perceived value of the company, leading to a decrease in stock price.